147 related articles for article (PubMed ID: 12589022)
21. Enhancer-Mediated Formation of Nuclear Transcription Initiation Domains.
Gibbons MD; Fang Y; Spicola AP; Linzer N; Jones SM; Johnson BR; Li L; Xie M; Bungert J
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012554
[TBL] [Abstract][Full Text] [Related]
22. Mediator and RNA polymerase II clusters associate in transcription-dependent condensates.
Cho WK; Spille JH; Hecht M; Lee C; Li C; Grube V; Cisse II
Science; 2018 Jul; 361(6400):412-415. PubMed ID: 29930094
[TBL] [Abstract][Full Text] [Related]
23. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes.
Kim JH; Yang CK; Heo K; Roeder RG; An W; Stallcup MR
Mol Cell; 2008 Aug; 31(4):510-519. PubMed ID: 18722177
[TBL] [Abstract][Full Text] [Related]
24. The mediator of RNA polymerase II.
Blazek E; Mittler G; Meisterernst M
Chromosoma; 2005 Mar; 113(8):399-408. PubMed ID: 15690163
[TBL] [Abstract][Full Text] [Related]
25. Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme.
Chiba N; Suldan Z; Freedman LP; Parvin JD
J Biol Chem; 2000 Apr; 275(15):10719-22. PubMed ID: 10753860
[TBL] [Abstract][Full Text] [Related]
26. PAF1 regulation of promoter-proximal pause release via enhancer activation.
Chen FX; Xie P; Collings CK; Cao K; Aoi Y; Marshall SA; Rendleman EJ; Ugarenko M; Ozark PA; Zhang A; Shiekhattar R; Smith ER; Zhang MQ; Shilatifard A
Science; 2017 Sep; 357(6357):1294-1298. PubMed ID: 28860207
[TBL] [Abstract][Full Text] [Related]
27. Temporal dissection of an enhancer cluster reveals distinct temporal and functional contributions of individual elements.
Thomas HF; Kotova E; Jayaram S; Pilz A; Romeike M; Lackner A; Penz T; Bock C; Leeb M; Halbritter F; Wysocka J; Buecker C
Mol Cell; 2021 Mar; 81(5):969-982.e13. PubMed ID: 33482114
[TBL] [Abstract][Full Text] [Related]
28. A nonradioactive method to determine levels of in vitro transcription in nuclear extracts.
Ayoubi TA; Van de Ven WJ
Anal Biochem; 1995 Feb; 225(1):190-2. PubMed ID: 7778782
[No Abstract] [Full Text] [Related]
29. Study of RNA Polymerase II Clustering inside Live-Cell Nuclei Using Bayesian Nanoscopy.
Chen X; Wei M; Zheng MM; Zhao J; Hao H; Chang L; Xi P; Sun Y
ACS Nano; 2016 Feb; 10(2):2447-54. PubMed ID: 26855123
[TBL] [Abstract][Full Text] [Related]
30. Assignment of a 15 kDa protein complex formed between the p160 coactivator ACTR and CREB binding protein.
Demarest SJ; Chung J; Dyson HJ; Wright PE
J Biomol NMR; 2002 Apr; 22(4):377-8. PubMed ID: 12018488
[No Abstract] [Full Text] [Related]
31. PNRC is a unique nuclear receptor coactivator that stimulates RNA polymerase III-dependent transcription.
Zhou D; Zhong S; Ye JJ; Quach KM; Johnson DL; Chen S
J Mol Signal; 2007 Jul; 2():5. PubMed ID: 17612402
[TBL] [Abstract][Full Text] [Related]
32. Enhancers, phase separation and the RNA polymerase II transfer model.
Gelder K; Bose D
Bioessays; 2023 Oct; 45(10):e2300128. PubMed ID: 37519125
[No Abstract] [Full Text] [Related]
33. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.
Wang Q; Carroll JS; Brown M
Mol Cell; 2005 Sep; 19(5):631-42. PubMed ID: 16137620
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer.
Chen DM; Dong R; Kachuri L; Hoffmann T; Jiang Y; Berndt SI; Shelley JP; Schaffer KR; Machiela MJ; Freedman ND; Huang WY; Li SA; Lilja H; Van Den Eeden SK; Chanock S; Haiman CA; Conti DV; Klein RJ; Mosley JD; Witte JS; Graff RE
medRxiv; 2023 May; ():. PubMed ID: 37205487
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic Coregulation of Androgen Receptor Signaling.
Fernandes RC; Leach DA; Bevan CL
Adv Exp Med Biol; 2022; 1390():277-293. PubMed ID: 36107325
[TBL] [Abstract][Full Text] [Related]
36. Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.
Kneppers J; Bergman AM; Zwart W
Adv Exp Med Biol; 2022; 1390():255-275. PubMed ID: 36107324
[TBL] [Abstract][Full Text] [Related]
37. CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers.
Waddell AR; Huang H; Liao D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201346
[TBL] [Abstract][Full Text] [Related]
38. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
Li L; Deng CX; Chen Q
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946224
[TBL] [Abstract][Full Text] [Related]
39. The mediator complex in genomic and non-genomic signaling in cancer.
Weber H; Garabedian MJ
Steroids; 2018 May; 133():8-14. PubMed ID: 29157917
[TBL] [Abstract][Full Text] [Related]
40. Interrelation of androgen receptor and miR-30a and miR-30a function in ER
Lyu S; Liu H; Liu X; Liu S; Wang Y; Yu Q; Niu Y
Oncol Lett; 2017 Oct; 14(4):4930-4936. PubMed ID: 29085503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
